Skip to main content
Erschienen in: Archives of Dermatological Research 8/2023

21.03.2023 | STUDY PROTOCOL

Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study

verfasst von: Yomna Mazid El-Hamd Neinaa, Iman Hamed El-Maadawy, Iman Aly Atteia, Dareen Abd El-Aziz Mohamed

Erschienen in: Archives of Dermatological Research | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Cell adhesion molecule 1 (CADM1) is one of the immunoglobulin super family adhesion molecules, that is proposed to contribute in the pathogenesis of various types of cutaneous T-cell lymphoma, including mycosis fungoides (MF). In this work, we decided to examine the immunohistochemical expression of CADM1 in MF specimens compared to premycotic parapsoriasis, benign inflammatory dermatosis and normal control skin specimens. 125 participants were enrolled (50 MF, 25 parapsoriasis, 25 inflammatory dermatosis, and 25 healthy controls). Patients were selected from the Outpatient Clinic of Dermatology and Venereology Department, Tanta University Hospitals. From all, 4 mm punch skin biopsies were taken and examined for CADM1 immunohistochemical expression. The current study revealed statistically significant upregulation of CADM1 expression in MF specimens in comparison to parapsoriasis, inflammatory dermatosis, and normal control specimens. Additionally, there was statistically significant positive correlation between CADM1 expression and progression of TNMB staging of MF disease. Therefore, it is possible to recommend CADM1 as a beneficial diagnostic immunohistochemical marker for differentiation between early stages of MF and both the premycotic parapsoriasis and benign inflammatory dermatosis. Moreover, it may be of value in early detection of neoplastic transformation of parapsoriasis as well as in assessment of MF progression.
Literatur
1.
2.
Zurück zum Zitat Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M et al (2019) The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 181(2):350–357CrossRefPubMed Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M et al (2019) The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 181(2):350–357CrossRefPubMed
3.
Zurück zum Zitat Reddy K, Bhawan J (2007) Histologic mimickers of mycosis fungoides: a review. J Cutan Pathol 34(7):519–525CrossRefPubMed Reddy K, Bhawan J (2007) Histologic mimickers of mycosis fungoides: a review. J Cutan Pathol 34(7):519–525CrossRefPubMed
4.
Zurück zum Zitat Chairatchaneeboon M, Thanomkitti K, Kim EJ (2022) Parapsoriasis-A diagnosis with an identity crisis: a narrative review. Dermatol Ther (Heidelb) 12(5):1091–1102CrossRefPubMed Chairatchaneeboon M, Thanomkitti K, Kim EJ (2022) Parapsoriasis-A diagnosis with an identity crisis: a narrative review. Dermatol Ther (Heidelb) 12(5):1091–1102CrossRefPubMed
5.
Zurück zum Zitat Shamim H, Johnson EF, Gibson LE, Comfere N (2019) Mycosis fungoides with spongiosis: a potential diagnostic pitfall. J Cutan Pathol 46(9):645–652CrossRefPubMed Shamim H, Johnson EF, Gibson LE, Comfere N (2019) Mycosis fungoides with spongiosis: a potential diagnostic pitfall. J Cutan Pathol 46(9):645–652CrossRefPubMed
6.
Zurück zum Zitat El-Hamd Neinaa YM, Sallam FA (2018) TOX as a diagnostic and prognostic marker for mycosis fungoides. J Egypt Women’s Dermatol Soc 15(1):15–22CrossRef El-Hamd Neinaa YM, Sallam FA (2018) TOX as a diagnostic and prognostic marker for mycosis fungoides. J Egypt Women’s Dermatol Soc 15(1):15–22CrossRef
7.
Zurück zum Zitat El-Shabrawi-Caelen L, Cerroni L, Medeiros LJ, McCalmont TH (2002) Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 26(4):450–457CrossRefPubMed El-Shabrawi-Caelen L, Cerroni L, Medeiros LJ, McCalmont TH (2002) Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 26(4):450–457CrossRefPubMed
8.
Zurück zum Zitat Ito A, Sugita K, Ikeda A, Yamamoto O (2019) CD4/CD8 double-negative mycosis fungoides: a case report and literature review. Yonago Acta Med 62(1):153–158CrossRefPubMedPubMedCentral Ito A, Sugita K, Ikeda A, Yamamoto O (2019) CD4/CD8 double-negative mycosis fungoides: a case report and literature review. Yonago Acta Med 62(1):153–158CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Raychaudhuri S, Rahvar M, Jedrych J, Karunamurthy A, Kruglov O, Rakfal S et al (2018) Dual-positive CD4/CD8 primary cutaneous peripheral T-Cell lymphoma previously classified as mycosis fungoides a tumor D’Emblée. Am J Dermatopathol 40(11):836–840CrossRefPubMed Raychaudhuri S, Rahvar M, Jedrych J, Karunamurthy A, Kruglov O, Rakfal S et al (2018) Dual-positive CD4/CD8 primary cutaneous peripheral T-Cell lymphoma previously classified as mycosis fungoides a tumor D’Emblée. Am J Dermatopathol 40(11):836–840CrossRefPubMed
10.
Zurück zum Zitat Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C (2014) Primary cutaneous T-cell lymphoma (mycosis fungoides and sézary syndrome): Part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 70(2):205–22 Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C (2014) Primary cutaneous T-cell lymphoma (mycosis fungoides and sézary syndrome): Part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 70(2):205–22
11.
Zurück zum Zitat Yuki A, Shinkuma S, Hayashi R, Fujikawa H, Kato T, Homma E et al (2018) CADM1 is a diagnostic marker in early-stage mycosis fungoides: multicenter study of 58 cases. J Am Acad Dermatol 79(6):1039–1046CrossRefPubMed Yuki A, Shinkuma S, Hayashi R, Fujikawa H, Kato T, Homma E et al (2018) CADM1 is a diagnostic marker in early-stage mycosis fungoides: multicenter study of 58 cases. J Am Acad Dermatol 79(6):1039–1046CrossRefPubMed
12.
Zurück zum Zitat Yamaguchi M, Morizane S, Hamada T, Miyake T, Sugaya M, Iwata H et al (2019) The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma. J Dermatol 46(11):967–977CrossRefPubMed Yamaguchi M, Morizane S, Hamada T, Miyake T, Sugaya M, Iwata H et al (2019) The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma. J Dermatol 46(11):967–977CrossRefPubMed
13.
Zurück zum Zitat Saito-Sasaki N, Sawada Y, Okada E, Nakamura M (2021) Cell adhesion molecule 1 (CADM1) Is an independent prognostic factor in patients with cutaneous squamous cell carcinoma. Diagnos (Basel) 11(5):830CrossRef Saito-Sasaki N, Sawada Y, Okada E, Nakamura M (2021) Cell adhesion molecule 1 (CADM1) Is an independent prognostic factor in patients with cutaneous squamous cell carcinoma. Diagnos (Basel) 11(5):830CrossRef
14.
Zurück zum Zitat Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP et al (2001) TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27(4):427–430CrossRefPubMed Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP et al (2001) TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27(4):427–430CrossRefPubMed
15.
Zurück zum Zitat Murakami Y (2005) Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 96(9):543–552CrossRefPubMed Murakami Y (2005) Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 96(9):543–552CrossRefPubMed
16.
Zurück zum Zitat Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T et al (2005) Over expression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105(3):1204–1213CrossRefPubMed Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T et al (2005) Over expression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105(3):1204–1213CrossRefPubMed
17.
Zurück zum Zitat Zhang S, Wang T, Liu Y (2020) CADM1: a molecule worth investigating in mycosis fungoides and sézary syndrome. J Am Acad Dermatol 82(4):141–142CrossRef Zhang S, Wang T, Liu Y (2020) CADM1: a molecule worth investigating in mycosis fungoides and sézary syndrome. J Am Acad Dermatol 82(4):141–142CrossRef
18.
Zurück zum Zitat Lindahl LM, Besenbacher S, Rittig AH, Celis P, Willerslev-Olsen A, Gjerdrum L et al (2018) Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study. Blood 131(7):759–770CrossRefPubMed Lindahl LM, Besenbacher S, Rittig AH, Celis P, Willerslev-Olsen A, Gjerdrum L et al (2018) Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study. Blood 131(7):759–770CrossRefPubMed
19.
Zurück zum Zitat Väkevä L, Sarna S, Vaalasti A, Pukkala E, Kariniemi AL, Ranki A (2005) A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Derm Venereol 85(4):318–323CrossRefPubMed Väkevä L, Sarna S, Vaalasti A, Pukkala E, Kariniemi AL, Ranki A (2005) A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Derm Venereol 85(4):318–323CrossRefPubMed
20.
Zurück zum Zitat Kempf W, Zimmermann AK, Mitteldorf C (2019) Cutaneous lymphomas-an update 2019. Hematol Oncol 37(Suppl 1):43–47CrossRefPubMed Kempf W, Zimmermann AK, Mitteldorf C (2019) Cutaneous lymphomas-an update 2019. Hematol Oncol 37(Suppl 1):43–47CrossRefPubMed
21.
Zurück zum Zitat Mateeva V, Tcharaktchiev D, Mateev G (2017) Role of lymphocytic immunohistochemical markers in early diagnosis of peripheral t-cell lymphoma of the skin–mycosis fungoides. J IMAB Annu Proc (Sci Pap) 23(3):1646–1650 Mateeva V, Tcharaktchiev D, Mateev G (2017) Role of lymphocytic immunohistochemical markers in early diagnosis of peripheral t-cell lymphoma of the skin–mycosis fungoides. J IMAB Annu Proc (Sci Pap) 23(3):1646–1650
22.
Zurück zum Zitat Tirumalae R, Panjwani PK (2012) Origin use of CD4, CD8, and CD1a immunostains in distinguishing mycosis fungoides from its inflammatory mimics: a pilot study. Indian J Dermatol 57(6):424–427CrossRefPubMedPubMedCentral Tirumalae R, Panjwani PK (2012) Origin use of CD4, CD8, and CD1a immunostains in distinguishing mycosis fungoides from its inflammatory mimics: a pilot study. Indian J Dermatol 57(6):424–427CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Florell SR, Cessna M, Lundell RB, Lundell RB, Boucher KM, Bowen GM et al (2006) Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol 125(5):727–736CrossRefPubMed Florell SR, Cessna M, Lundell RB, Lundell RB, Boucher KM, Bowen GM et al (2006) Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol 125(5):727–736CrossRefPubMed
24.
Zurück zum Zitat Gambichler T, Bischoff S, Bechara FG, Altmeyer P, Kreuter A (2008) Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J Dermatol Sci 49(2):125–132CrossRefPubMed Gambichler T, Bischoff S, Bechara FG, Altmeyer P, Kreuter A (2008) Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J Dermatol Sci 49(2):125–132CrossRefPubMed
26.
Zurück zum Zitat Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S et al (2018) A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides. Clin Immunol 193:121–122CrossRefPubMed Mashima E, Sawada Y, Yamaguchi T, Yoshioka H, Ohmori S, Haruyama S et al (2018) A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides. Clin Immunol 193:121–122CrossRefPubMed
27.
Zurück zum Zitat Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M (2020) The role of cell adhesion molecule 1 (CADM1) in cutaneous malignancies. Int J Mol Sci 21(24):9732CrossRefPubMedPubMedCentral Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M (2020) The role of cell adhesion molecule 1 (CADM1) in cutaneous malignancies. Int J Mol Sci 21(24):9732CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Masuda M, Maruyama T, Ohta T, Ito A, Hayashi T, Tsukasaki K et al (2010) CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells. J Biol Chem 285(20):15511–22CrossRefPubMedPubMedCentral Masuda M, Maruyama T, Ohta T, Ito A, Hayashi T, Tsukasaki K et al (2010) CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells. J Biol Chem 285(20):15511–22CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yuki A, Ansai O, Abe R (2020) CADM1 expression of mast cells in mycosis fungoides. J Am Acad Dermatol 82(4):e143–e144CrossRefPubMed Yuki A, Ansai O, Abe R (2020) CADM1 expression of mast cells in mycosis fungoides. J Am Acad Dermatol 82(4):e143–e144CrossRefPubMed
Metadaten
Titel
Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study
verfasst von
Yomna Mazid El-Hamd Neinaa
Iman Hamed El-Maadawy
Iman Aly Atteia
Dareen Abd El-Aziz Mohamed
Publikationsdatum
21.03.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 8/2023
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-023-02600-x

Weitere Artikel der Ausgabe 8/2023

Archives of Dermatological Research 8/2023 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.